TransMedics Group, Inc., was registered in August 1998. The company is a commercial-stage medical technology company that provides organ transplant treatment to patients with end-stage organ failure in multiple disease states. The company developed the catenary to replace the decades-old standard of care. The company's innovative catenary technology replicates many aspects of the natural living and functional environment of external human organs. OCS represents a change in approach that transplants preservation from a static state to a dynamic environment, enabling new functions, including organ optimization and evaluation. 

TMDX

TMDX Profile